ClinicalTrials.gov
ClinicalTrials.gov Menu

4SC-201 (Resminostat) and Sorafenib in Advanced Hepatocellular Carcinoma (Shelter)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00943449
Recruitment Status : Completed
First Posted : July 22, 2009
Last Update Posted : January 16, 2014
Sponsor:
Information provided by:
4SC AG